Nanostructure-mediated drug delivery

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 1, Issue 1, 2005, Pages 22-30

  Hughes, Gareth A ^a  

^a ZYVEX CORPORATION   (United States)

Author keywords

Drug delivery; Nanomedicine; Nanotechnology

Indexed keywords

DRUG DELIVERY; NANOMEDICINE; NANOSCALE PHENOMENA; SYSTEMIC SIDE EFFECTS;

BIOTECHNOLOGY; MANUFACTURE; MEDICINE; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY; NUCLEIC ACIDS; SEMICONDUCTOR MATERIALS;

CONTROLLED DRUG DELIVERY;

BUTYRIC ACID DERIVATIVE; CARBON; CYANOACRYLATE DERIVATIVE; DENDRIMER; DRUG CARRIER; GOLD; LIPID; MACROGOL; NANOPARTICLE; NANOTUBE; NUCLEIC ACID; PALLADIUM; PEPTIDE; PLATINUM; POLYAMIDOAMINE; POLYCAPROLACTONE; POLYETHYLENEIMINE; POLYGLUTAMIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYPROPYLENE; POLYSACCHARIDE; SILICON; SILICON DIOXIDE; SILVER;

BIOCOMPATIBILITY; BIODEGRADABILITY; CHEMICAL STRUCTURE; COMBUSTION; COMPOSITE MATERIAL; DRUG DELIVERY SYSTEM; DRUG RELEASE; EXCITATION CONTRACTION COUPLING; HYDROGEL; LASER SURGERY; MICELLE; NANOTECHNOLOGY; PARTICLE SIZE; POROSITY; REVIEW; STRUCTURE ANALYSIS; SUSTAINABLE DEVELOPMENT;

CAPSULES; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; NANOSTRUCTURES; NANOTECHNOLOGY; PHARMACEUTICAL PREPARATIONS;

EID: 26244441643     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2004.11.009     Document Type: Review

References (128)

1. Kefalides P.T. New methods for drug delivery. Ann Intern Med 128 (1998) 1053-1055
2. Bradbury J. Beyond pills and jabs. Lancet 362 (2003) 1984-1985
3. Henry CM. New wrinkles in drug delivery. Chem Eng News 82 (2004) 37-42
4. VisionGain. Drug delivery 2003: new technologies in the global market. VisionGain, June 2003.
5. El-Aneed A. An overview of current delivery systems in cancer gene therapy. J Controlled Release 94 (2004) 1-14
6. D'Aquino R. Good drug therapy: it's not just the molecule-it's the delivery. CEP Magazine 100 (2004) 15S-17S
7. Roco M.C. The US National Nanotechnology Initiative after 3 years (2000-2003). J Nanoparticle Res 6 (2004) 1-10
8. Dubin C.H. Special delivery: pharmaceutical companies aim to target their drugs with nano precision. Mech Eng Nanotechnol 126 Suppl. (2004) 10-12
9. Dass C.R., and Su T. Particle-mediated intravascular delivery of oligonucleotides to tumors: associated biology and lessons from genotherapy. Drug Delivery 8 (2001) 191-213
10. Courrier H.M., Butz N., and Vandamme T.F. Pulmonary drug delivery systems: recent developments and prospects. Crit Rev Ther Drug Carrier Syst 19 (2002) 425-498
11. Senior K. "Nano-dumpling" with drug delivery potential. Mol Med Today 4 (1998) 321
12. LaVan D.A., Lynn D.M., and Langer R. Moving smaller in drug discovery and delivery. Nat Rev Drug Discovery 1 (2002) 77-84
13. LaVan D.A., McGuire T., and Langer R. Small-scale systems for in vivo drug delivery. Nat Biotechnol 21 (2003) 1184-1191
14. Ravi Kumar M.N. Nano and microparticles as controlled drug delivery devices. J Pharm Pharm Sci 3 (2000) 234-258
15. Desai M.P. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 13 (1996) 1838-1845
16. Hussain N., Jaitley V., and Florence A.T. Recent advances in the understanding of uptake of microparticulates across the gastrointestinal lymphatics. Adv Drug Delivery Rev 50 (2001) 107-142
17. Kohli A.K., and Alpar H.O. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int J Pharm 275 (2004) 13-17
18. Brzoska M., Langer K., Coester C., Loitsch S., Wagner T.O.F., and Mallinckrodt Cv. Incorporation of biodegradable nanoparticles into human airway epithelial cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases. Biochem Biophys Res Commun 318 (2004) 562-570
19. Martin C.R., and Kohli P. The emerging field of nanotube biotechnology. Nat Rev Drug Discovery 2 (2003) 29-37
20. Drummond D.C., Meyer O., Hong K., and Kirpotin D.B. Papahadjopoulos. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol Rev 51 (1999) 691-743
21. Moselhy J., Wu X.Y., Nicholov R., and Kodaria K. In vitro studies of the interaction of poly(NIPAm/MAA) nanoparticles with proteins and cells. J Biomat Sci Polymer Ed 11 (2000) 123-147
22. Costa P., and Sousa Lobo J.M. Evaluation of mathematical models describing drug release from estradiol transdermal systems. Drug Dev Ind Pharm 29 (2003) 89-97
23. Zhang S. Emerging biological materials through molecular self-assembly. Biotechnol Adv 20 (2002) 321-339
24. Mirkin C.A., Letsinger R.L., Mucic R.C., and Storhoff J.J. A DNA method for rationally assembling nanoparticles into macroscopic materials. Nature 382 (1996) 607-609
25. Hansma H.G., Kasuya K., and Oroudjev E. Atomic force microscopy imaging and pulling of nucleic acids. Curr Opin Struct Biol 14 (2004) 380-385
26. Cui D. Advance and prospect of bionanomaterials. Biotechnol Prog 19 (2003) 683-692
27. Ai H. Biomedical applications of electrostatic layer-by-layer nano-assembly of polymers, enzymes, and nanoparticles. Cell Biochem Biophys 39 (2003) 23-43
28. Ai H. Electrostatic layer-by-layer nanoassembly on biological microtemplates: platelets. Biomacromolecules 3 (2002) 560-564
29. Mamalis A.G., Vogtländer L.O.G., and Markopoulos A. Nanotechnology and nanostructured materials: trends in carbon nanotubes. Precision Eng 28 (2004) 16-30
30. Lowe C.R. Nanobiotechnology: the fabrication and applications of chemical and biological nanostructures. Curr Opin Struct Biol 10 (2000) 428-434
31. Lanyi J.K. Proton pumps: mechanism of action and applications. Trends Biotechnol 19 (2001) 140-144
32. Zhang S., Marini D.M., Hwang W., and Santoso S. Design of nanostructured biological materials through self-assembly of peptides and proteins. Curr Opin Chem Biol 6 (2002) 865-871
33. Cans A.-S., Wittenberg N., Karlsson R., Sombers L., Karlsson M., Orwar O., et al. Artificial cells: unique insights into exocytosis using liposomes and lipid nanotubes. Proc Natl Acad Sci U S A 100 (2003) 400-404
34. Tomii Y. Lipid formulations as a drug carrier for drug delivery. Curr Pharm Design 8 (2002) 467-474
35. Fukui H., Koike T., Saheki A., Sonoke S., Tomii Y., and Seki J. Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS). Int J Pharm 263 (2003) 51-60
36. Fukui H., Koike T., Nakagawa T., Saheki A., Sonoke S., Tomii Y., et al. Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations. Int J Pharm 267 (2003) 101-112
37. Seki J., Sonoke S., Saheki A., Koike T., Fukui H., Doi M., et al. Lipid transfer protein transports compounds from lipid nanoparticles to plasma lipoproteins. Int J Pharm 275 (2004) 239-248
38. Seki J. A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting. Int J Pharm 273 (2004) 75-83
39. Cevc G. Lipid vesicles and other colloids as drug carriers on the skin. Adv Drug Delivery Rev 56 (2004) 675-711
40. Fang J.-Y., Leu Y.-L., Chang C.-C., Lin C.-H., and Tsai Y.-H. Lipid nano/submicron emulsions as vehicles for topical flurbiprofen delivery. Drug Delivery 11 (2004) 97-105
41. Lundberg B.B., Risovic V., Ramaswamy M., and Wasan K.M. A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J Controlled Release 86 (2003) 93-100
42. Kayser O., and Kiderlin A.F. Delivery strategies for antiparasitics. Expert Opin Invest Drugs 12 (2003) 197-207
43. Fernandez-Lopez S., Kim H.-S., Choi E.C., Delgado M., Granja J.R., Khasanov A., et al. Antibacterial agents based on the cyclic D. L-α-peptide architecture. Nature 412 (2001) 452-455
44. Djalali R., Samson J., and Matsui H. Doughnut-shaped peptide nano-assemblies and their applications as nanoreactors. J Am Chem Soc 126 (2004) 7935-7939
45. Mao S., Shuai X., Unger F., Simon M., Bi D., and Kissel T. The depolymerization of chitosan: effects on physicochemical and biological properties. Int J Pharm 281 (2004) 45-54
46. Park J.H., Kwon S., Nam J.-O., Park R.-W., Chung H., Seo S.B., et al. Self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid for RGD peptide delivery. J Controlled Release 95 (2004) 579-588
47. Van der Lubben I.M. Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 14 (2001) 201-207
48. Bozkir A., and Saka O.M. Chitosan nanoparticles for plasmid DNA delivery: effect of chitosan molecular structure on formulation and release characteristics. Drug Delivery 11 (2004) 107-112
49. Yamada T., Ueda M., Seno M., Kondo A., Tanizawa K., and Kuroda S. Novel tissue and cell type-specific gene / drug delivery system using surface engineered Hepatitis B virus nano-particles. Curr Drug Targets Infect Disorders 4 (2004) 163-167
50. Niemeyer C.M. Semi-synthetic nucleic acid-protein conjugates: applications in life sciences and nanobiotechnology. Rev Mol Biotechnol 82 (2001) 47-66
51. Barza M., Stuart M., and Szoka F. Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes. Invest Ophthalmol Visual Sci 28 (1987) 893-900
52. Moghimi S.M., and Szebeni J. Stealth liposomes and long circulation nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 42 (2003) 463-478
53. Peer D. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int J Cancer 108 (2004) 780-789
54. Coldren B., Boyer C., Kisak E.T., Evans C.A., and Zasadzinski J.A. The vesosome-a multicompartment drug delivery vehicle. Curr Med Chem 11 (2004) 199-219
55. Cevc G. Hydration-driven transport of deformable lipid vesicles through fine pores and the skin barrer. Biophys J 84 (2003) 1010-1024
56. Landgraf W., Li N.-H., and Benson J.R. Polymer microcarrier exhibiting zero-order release. Drug Delivery Technol (2003) 3
57. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discovery 2 (2003) 347-360
58. Li Y.Y., Cunin F., Link J.R., Cao T., Belts R.E., Reiver S.H., et al. Polymer replicas of photonic porous silicon for sensing and drug delivery applications. Science 299 (2003) 2045-2048
59. Dalby M.J., Berry C.C., Riehle M.O., Sutherland D.S., Agheli H., and Curtis A.S.G. Attempted endocytosis of nano-environment produced by colloidal lithography by human fibroblasts. Exp Cell Res 295 (2004) 387-394
60. Couvreur P., Barratt G., Fattal E., Legrand P., and Vauthier C. Nanocapsule technology: a review. Crit Rev Ther Drug Carrier Syst 19 (2002) 99-134
61. Lu Y., and Chen S.C. Micro and nano-fabrication of biodegradable polymers for drug delivery. Adv Drug Delivery Rev 56 (2004) 1621-1633
62. Frenot A., and Chronakis I.S. Polymer nanofibers assembled by electrospinning. Curr Opin Colloid Interface Sci 8 (2003) 64-75
63. Ulrich K.E., Cannizzaro S.M., Langer R.S., and Shakeshelf K.M. Polymeric systems for controlled drug release. Chem Rev 99 (1999) 3181-3198
64. Panyam J., and Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Delivery Rev 55 (2003) 329-347
65. Panyam J., Dali M.M., Sahoo S.K., Ma W., Chakravarthi S.S., Amidon G.L., et al. Polymer degradation and in vitro release of a model protein from poly(d,l-lactide-co-glycolide) nano- and microparticles. J Controlled Release 92 (2003) 173-187
66. Nugent J., Wan Po A.L., and Scott E.M. Design and delivery of non-parenteral vaccines. J Clin Pharm Ther 23 (1998) 257-285
67. Katare Y.K., Panda A.K., Lalwani K., Haque I.U., and Ali M.M. Potentiation of immune response from polymer-entrapped antigen: toward development of single dose tetanus toxoid vaccine. Drug Delivery 10 (2003) 231-238
68. Lee K.E., Kim B.K., and Yuk S.H. Biodegradable polymeric nanospheres formed by temperature-induced phase transition in a mixture of poly(lactide-co-glycolide) and poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymer. Biomacromolecules 3 (2002) 1115-1119
69. Brannon-Peppas L., and Blanchette J.O. Nanoparticle and targeted systems for cancer therapy. Adv Drug Delivery Rev 56 (2004) 1649-1659
70. Rosiak J.M., Janik I., Kadlubowski S., Kozicki M., Kujawa P., Stasica P., et al. Nano-, micro- and macroscopic hydrogels synthesized by radiation technique. Nucl Instruments Methods Phys Res B 208 (2003) 325-330
71. Ggiannavola C., Bucolo C., Maltese A., Paolino D., Vandelli M.A., Puglisi G., et al. Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm Res 20 (2003) 584-590
72. Kompella U.B. Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression. Invest Ophthalmol Visual Sci 44 (2003) 1192-1201
73. Sanchez A., Tobio M., Gonzalez L., Fabra A., and Alonso M.J. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur J Pharm Sci 18 (2003) 221-229
74. Salgueiro A., Gamisans F., Espina M., Alcober X., Garcia M.L., and Egea M.A. Cyclophosphamide-loaded nanospheres: analysis of the matrix structure by thermal and spectroscopic methods. J Microencapsulation 19 (2002) 305-310
75. Piddubnyak V., Kurcok P., Matuszowicz A., Glowala M., Fiszer-Keirzkowska A., Jedlinski Z., et al. Oligo-3-hydroxybutyrates as potential carriers for drug delivery. Biomaterials 25 (2004) 5271-5279
76. Kim J.I., Jun Y.J., Seong J.-Y., Jun M.J., and Sohn Y.S. Synthesis and characterization of nanosized poly(organophosphazenes) with methoxy-poly(ethylene glycol) and dipeptide ethyle esters as side groups. Polymer 45 (2004) 7083-7089
77. Moghimi S.M. Capture of stealth nanoparticles by the body's defences. Crit Rev Ther Drug Carrier Syst 18 (2001) 527-550
78. Kumar R., Ming-Hsiung C., Parmar V.S., Samuelson L.A., Kumar J., Nicolosi R., et al. Supramolecular assemblies based on copolymers of PEG600 and functionalized aromatic diesters for drug delivery applications. J Am Chem Soc 126 (2004) 10640-10644
79. Vila A., Gill H., McCallion O., and Alonso M.J. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Controlled Release 98 (2004) 231-244
80. Luu Y.K. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Controlled Release 89 (2003) 341-353
81. Zhang L., Hu Y., Jiang X., Yang C., Lu W., and Yah Y.H. Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice. J Controlled Release 96 (2004) 135-148
82. Rodrigues J.S., Santos-Magalhaes N.S., Coelho L.C.B.B., Couvreur P., Ponchel G., and Gref R. Novel core(polyester)-shell(polysaccharide) nanoparticles: protein loading and surface modification with lectins. J Controlled Release 92 (2003) 103-112
83. Van Domeselaar G.H., Kwon G.S., Andrew L.C., and Wishart D.S. Application of solid phase peptide synthesis to engineering PEO-peptide block copolymers for drug delivery. Colloids Surfaces B Biointerfaces 30 (2003) 323-334
84. Panoyan A., Quesnel R., and Hildgen P. Injectable nanospheres from a novel multiblock copolymer: cytocompatibility, degradation and in vitro release studies. J Microencapsulation 20 (2003) 745-758
85. Otsuka H., Nagasaki Y., and Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv Drug Delivery Rev 55 (2003) 403-419
86. Kim I.H., Park J.H., Cheong I.W., and Kim J.H. Swelling and drug release behavior of tablets coated with aqueous hydroxypropyl methylcellulose phthalate (HPMCP) nanoparticles. J Controlled Release 89 (2003) 225-233
87. Pricl S., Fermeglia M., Ferrone M., and Asquini A. Scaling properties in the molecular structure of three-dimensional, nanosized phenylene-based dendrimers as studied by atomistic molecular dynamics simulations. Carbon 41 (2003) 2269-2283
88. Namazi H., and Adeli M. Dendrimers of citric acid and poly(ethylene glycol) as the new drug-delivery agents. Biomaterials 26 (2004) 1175-1183
89. Cloninger M.J. Biological applications of dendrimers. Curr Opin Chem Biol 6 (2002) 742-746
90. Hussain M., Shchepinov M., Sohail M., Benter I.F., Hollins A.J., Southern E.M., et al. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. J Controlled Release 99 (2004) 139-155
91. Yang H., and Lopina S.T. Penicillin V-conjugated PEG-PAMAM star polymers. J Biomat Sci Polymer Ed 14 (2003) 1043-1056
92. Quintana A., Raczka E., Piehler L., Lee I., Myc A., Majoros I., et al. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 19 (2002) 1310-1316
93. Meijer E.W., and Van Genderen M.H.P. Chemistry: dendrimers set to self-destruct. Nature 426 (2003) 128-129
94. Kannan S., Kolhe P., Raykova V., Glibatec M., Kannan R.M., Lieh-Lai M., et al. Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells. J Biomat Sci Polymer Ed 15 (2004) 311-330
95. Jevprasesphant R., Penny J., Attwood D., and D'Emanuele A. Transport of dendrimer nanocarriers through epithelial cells via the transcellular route. J Controlled Release 97 (2004) 259-267
96. Neerman M.F., Zhang W., Parrish A.R., and Simanek E.E. In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery. Int J Pharm 281 (2004) 129-132
97. Tansey W., Ke S., Cao X.Y., Pasuelo M.J., Wallace S., and Li C. Synthesis and characterization of branched poly(L-glutamic acid) as a biodegradable drug carrier. J Controlled Release 94 (2004) 39-51
98. Paleos C.M., Tsiourvas D., Sideratou Z., and Tziveleka L. Acid- and salt-triggered multifunctional poly(propylene imine) dendrimer as a prospective drug delivery system. Biomacromolecules 5 (2004) 524-529
99. Sashiwa H., and Aiba S.-I. Chemically modified chitin and chitosan as biomaterials. Prog Polymer Sci 29 (2004) 887-908
100. Aulenta F., Hayes W., and Rannard S. Dendrimers: a new class of nanoscopic containers and drug delivery devices. Eur Polymer J 39 (2003) 1741-1771
101. Prinz A.V., Prinz V.Ya., and Seleznev V.A. Semiconductor micro- and nanoneedles for microinjections and ink-jet printing. Microelectronic Eng 67-68 (2003) 782-788
102. Tao S.L., and Desai T.A. Microfabricated drug delivery systems: from particles to pores. Adv Drug Delivery Rev 55 (2003) 315-328
103. Chen J.-F., Ding H.-M., Wang J.-X., and Shao L. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 25 (2004) 723-727
104. Li Z.-Z., Wen L.-X., Shao L., and Chen J.-F. Fabrication of porous hollow silica nanoparticles and their applications in drug release control. J Controlled Release 98 (2004) 245-254
105. Li X., St John J., Coffer J.L., Chen Y., Pinizzotto R.F., Newey J., et al. Porosified silicon wafer structures impregnated with platinum anti-tumor compounds: Fabrication, characterization, and diffusion studies. Biomed Microdevices 2 (2000) 265-272
106. Weis R.P., Montchamp J.-L., Coffer J.L., Attiah D.G., and Desai T.A. Calcified nanostructured silicon wafer surfaces for biosensing: effects of surface modification on bioactivity. Dis Markers 18 (2002) 159-165
107. Leoni L., and Desai T.A. Micromachined biocapsules for cell-based sensing and delivery. Adv Drug Delivery Rev 56 (2004) 211-229
108. Chen J.F., Ding H.M., Wang J.X., and Shao L. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application. Biomaterials 25 (2004) 723-727
109. Jain T.K., Roy I., De T.K., and Maitra A.N. Nanometer silica particles enacapsulating active compounds: a novel ceramic drug carrier. J Am Chem Soc 120 (1998) 11092-11095
110. Sameti M., Bohr G., Ravi Kumar M.N., Kneuer C., Bakowsky U., Nacken M., et al. Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery. Int J Pharm 266 (2003) 51-60
111. Gogotsi Y., Naguib N., and Libera L.A. In situ chemical experiments in carbon nanotubes. Chem Phys Lett 365 (2002) 354-360
112. Becker L., Poreda R.J., and Bunch T.E. An extraterrestrial carbon carrier phase for noble gases. Proc Natl Acad Sci U S A 97 (2000) 2979-2983
113. Shi Kam N.W., Jessop T.C., Wender P.A., and Dai H. Nanotube molecular transporters: internalization of carbon nanotube-protein conjugates into mammalian cells. J Am Chem Soc 126 (2004) 6850-6851
114. Pantarotto D., Partidos C.D., Hoebeke J., Brown F., Kramer E., Briand J.P., et al. Immunization with peptide-functionalized carbon nanotubes enhances virus-specific neutralizing antibody responses. Chem Biol 10 (2003) 961-969
115. Panhuis M. Vaccine delivery by carbon nanotubes. Chem Biol 10 (2003) 897-898
116. Truskett T.M. The subtleties of water in small spaces. Proc Natl Acad Sci U S A 100 (2003) 10139-10140
117. Kalra A., Garde S., and Hummer G. Osmotic water transport through carbon nanotube membranes. Proc Natl Acad Sci U S A 100 (2003) 10175-10180
118. Zhu F., and Schulten K. Water and proton conduction through carbon nanotubes as models for biological channels. Biophys J 85 (2003) 236-244
119. Gao H., Kong Y., and Cui D. Spontaneous insertion of DNA oligonucleotides into carbon nanotubes. Nano Lett 3 (2003) 471-473
120. Li H., Wang D.Q., Liu B.L., and Gao L.Z. Synthesis of a novel gelatin-carbon nanotubes hybrid hydrogel. Colloids Surfaces B Biointerfaces 33 (2004) 85-88
121. Gonzalez K.A., Wilson L.J., Wu W., and Nancollas G.H. Synthesis and in vitro characterization of a tissue-selective fullerene: vectoring C(60)(OH)(16)AMBP to mineralized bone. Bioorganic Med Chem 10 (2002) 1991-1997
122. Foley S., Crowley C., Smaihi M., Bonfils C., Erlanger B.F., Seta P., et al. Cellular localization of a water-soluble fullerene derivative. Biochem Biophys Res Commun 294 (2002) 116-119
123. Lin A.M.Y., Chyi B.Y., Wang S.D., Yu H.-H., Kanakamma P.P., Lu T.-Y., et al. Carboxyfullerene prevents iron-induced oxidative stress in rat brain. J Neurochem 72 (1999) 1634-1640
124. Fumelli C., Marconi A., Salvioli S., Straface E., Malorni W., Offidani A.M., et al. Carboxyfullerenes protect human keratinocytes from ultraviolet-B-induced apoptosis. J Invest Dermatol 115 (2000) 835-841
125. Tsao N., Luh T.-Y., Chou C.-K., Chang T.-Y., Wu J.-J., Liu C.-C., et al. In vitro action of carboxyfullerene. J Antimicrob Chemother 49 (2002) 641-649
126. Sun Y., Mayers B.T., and Xia Y. Template-engaged replacement reaction: a one-step approach to the large scale synthesis of metal nanostructures with hollow interiors. Nano Lett 2 (2002) 481-485
127. Rösler A., Vandermeulen G.W., and Klok H.A. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Delivery Rev 53 (2001) 95-108
128. Bagwe R.P., Zhao X., and Tan W. Bioconjugated luminescent nanoparticles for biological applications. J Dispersion Sci Technol 24 (2003) 453-464